Jack Harley


Jack Harley is a clinical neuroscience graduate with experience in the longevity biotechnology industry. Jack has worked with a clinical-stage pharmaceutical company to develop new therapeutics for cognitive impairment and neurodegenerative diseases, and lectured at the University of Oxford in clinical neuroscience. Jack is currently completing a PhD in aging and epigenetics at the University of New South Wales in Sydney, Australia.